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Abstract
Purpose of review—We summarize recent experimental and computational studies that
investigate molecular and cellular mechanisms of sprouting angiogenesis. We discuss how
experimental tools have unveiled new opportunities for computational modeling by providing
detailed phenomenological descriptions and conceptual models of cell-level behaviors
underpinned by high-quality molecular data. Using recent examples, we show how new
understanding results from bridging computational and experimental approaches.
Recent findings—Experimental data extends beyond the tip cell vs. stalk cell paradigm, and
involves numerous molecular inputs such as VEGF and Notch. This data is being used to generate
and validate computational models, which can then be used to predict the results of hypothetical
experiments that are difficult to perform in the laboratory, and to generate new hypotheses that
account for system-wide interactions. As a result of this integration, descriptions of critical
gradients of growth factor-receptor complexes have been generated, and new modulators of cell
behavior have been described.
Summary—We suggest that the recent emphasis on the different stages of sprouting
angiogenesis, and integration of experimental and computational approaches, should provide a
way to manage the complexity of this process and help identify new regulatory paradigms and
therapeutic targets.
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Blood vessel formation is critical to the development of all vertebrates, and co-option or
dysfunction of blood vessels in diseases such as atherosclerosis and cancer is a major cause
of mortality in humans. Thus, the molecular and cellular mechanisms that contribute to
formation of a vascular network are potential therapeutic targets, and our understanding of
these regulatory inputs has increased exponentially in the last several years. Indeed, we now
have clinically approved therapies (e.g. Lucentis) that are widely prescribed in certain
disease settings, such as diabetic retinopathy, to effectively modulate key molecular signals,
such as the vascular endothelial growth factor (VEGF) signaling pathway. We understand
that differential responses to inputs by the endothelial cells that comprise the nascent
vessels, so that some cells migrate while others divide, is important for the expansion of
blood vessel networks via sprouting angiogenesis. We know many of the molecular
pathways that contribute information for proper vessel sprouting, and we know that some of
them, such as VEGF and Notch, integrate with each other to establish endothelial
heterogeneity and appropriate responses.
We have also come to realize that blood vessel sprouting is a complex process, and a
complete understanding of its regulation will require knowledge of which inputs are critical,
and when in time and space they are important. In addition to temporal and spatial
information, quantitative aspects and integration of different signaling pathways are also
important parameters for a complete picture of vessel sprouting and network formation.
Sophisticated experimental tools are increasingly available to tackle these issues. For
example, it is now possible, using recombination-based genetic manipulations, to regulate
the expression of exogenous genes or to selectively remove gene function in both time and
space in vivo in mouse and to some extent in zebrafish, and this ability has been essential to
developing the paradigms described below for blood vessel sprouting. We also have
achieved high-resolution imaging in zebrafish embryos and mouse embryonic tissues and
derivatives (i.e. embryonic stem (ES) cell differentiation) to provide spatial information, and
adaptation of these imaging modalities for live imaging has begun to provide temporal
information as well.
Complementary to experimental approaches is the recent development of theoretical
computational models to better understand the system-level principles (Figure 1) that
underpin blood vessel formation; these models can also be used to generate testable
hypotheses. Theoretical models can quantitatively compute what is often difficult or
impossible to measure experimentally, account for the combinations and permutations of
signaling networks that give rise to observable phenotypes, and offer the researcher an
inexpensive “playground” upon which to test hypotheses that may be challenging to test
experimentally. Recent theoretical models of angiogenesis have offered some new and
different insights, which have suggested new lines of basic research and opened up new
possibilities for therapy design.
This short review will provide a brief description of sprouting angiogenesis, and suggest that
dividing the process into distinct stages is helpful both experimentally and computationally.
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We summarize recent computational models of sprouting angiogenesis and vessel network
formation, including new work from our groups. Finally, we will discuss some of the
important challenges and critical questions going forward.
SPROUTING ANGIOGENESIS
Endothelial cells differentiate from mesoderm and form nascent vessels via a process called
vasculogenesis; once a primitive vessel is formed, further expansion and interconnection
with other vessels proceeds primarily via sprouting angiogenesis, the coordinated outward
migration of groups of endothelial cells called sprouts [1]. This migration is accompanied by
endothelial cell division to allow for expansion of the network. The concept that endothelial
cells have different responses to pro-angiogenic cues such as VEGF-A is exemplified by the
understanding that sprouts contain both tip cells and stalk cells [2]. Tip cells initially
respond to VEGF-A by migrating outward from the parent vessel, while stalk cells behind
the leading tip cell migrate only passively and divide in response to VEGF-A. Subsequent
studies showed that Notch signaling within the sprout is important for allocation of proper
numbers of tip cells and stalk cells [3-5]. This concept has been expanded to include
endothelial cells that are neither tip nor stalk, and these cells are called phalanx cells or
lateral base cells if next to the emerging sprout [6, 7]. Pericytes are also associated with
nascent vessels and affect endothelial cell responses to signals in poorly understood ways.
Overall, pericyte coverage of a vessel is associated with quiescence, analogous to the
phalanx phenotype; however pericytes also interact with stalk cells and even tip cells during
sprouting [8*]. Recent work has shown regulation of vessel sprouting via micro RNAs in
both mouse and zebrafish [9, 10*,11**]. Angiogenic sprouting also appears to be fine-tuned
by modifications to Notch signaling via the deacetylase Sirtuin 1 [12*].
Sprouting is accompanied by lumen formation that occurs behind the migrating tip cell, and
in many sprouting vascular beds lumenogenesis is considered to be a property of stalk cells
but not tip cells [13]. Lumen formation allows for blood flow that often initiates the process
of remodeling the primitive vessel network that forms via angiogenesis. Although poorly
understood, recent work is consistent with a cord-hollowing mechanism of vascular lumen
formation, whereby endothelial cell-cell borders set up an apical domain, and subsequent
shape changes lead to lumen formation [14-16*]. The final step in sprouting is the fusion of
a sprout with another sprout or vessel to form a new connection. Although this process is
also not well-understood, a recent study suggests that in some cases macrophages may act as
chaperones to organize fusion events [17*].
The recent recognition of sprouting angiogenesis as a multi-staged process (Figure 2) has
been facilitated by in vitro and in vivo assays that are amenable to high-resolution fixed and
live imaging with single-cell resolution. These models can also be perturbed genetically
and/or pharmacologically, and thus have provided detailed descriptions of molecular
pathways that are important to the overall process of angiogenesis in the given model
system. However, these pathways have not yet been scrutinized for their role within each
stage of this complex process. In vivo, the post-natal mouse retina and the zebrafish embryo
have been crucial to elucidating angiogenic mechanisms. This has been both advantageous
and problematic – many studies use similar models and thus can be compared; however,
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much experimental data that supports our “generic” conceptual models of vessel sprouting
comes from a few fairly specialized vessel beds. For example, the vasculature of the
mammalian retina forms outwardly from the optic nerve during the first post-natal week
[18]. This vessel network is accessible to physical manipulation via intraocular injection and
genetic perturbation, and it is amenable to high-resolution imaging. Similarly, the zebrafish
embryo has been spectacularly successful as a model for live imaging of sprouting vessels,
and it is also tractable for forward genetic screens that have yielded novel molecular players
in sprouting [19]. In vitro models of sprouting angiogenesis are many and varied, and most
are amenable to live imaging. Among the most robust is a sprouting model of endothelial
cells in which HUVEC-coated beads in a fibrin matrix sprout and form lumenized vessels
[20]. Another model involves a programmed differentiation of mouse ES cells to form
lumenized vessels over the course of a week [21]. In a variant of this model partially
differentiated ES cell-derived embryoid bodies are embedded in collagen with added VEGF-
A, and developing vessels sprout outward into the matrix [22].
These and other recently established experimental models have provided a rich trove of
information about cell behaviors and their molecular regulation during blood vessel
sprouting, and more simple experimental set-ups (i.e. micro-fluidics chambers) have
provided quantitative and spatial information about signaling cues [23, 24]. It is apparent,
however, that a full understanding of how angiogenic sprouting and vessel network
formation is regulated will require the synthesis and integration of data from multiple
perturbations and different model systems. It will be important to understand which
signaling paradigms are consistent across (or unique to) specific tissues and vascular beds,
to determine how capillary sprouting differs across species and between in vitro and in vivo
models, and to explore network-level relationships between relevant molecular signaling
pathways. An additional goal is to identify new drug targets that may be concealed by
redundant pathways or genetic compensation. With these aims in mind, a number of useful
theoretical computational models (Figure 3) have recently emerged that provide a more
quantitative and synthesized perspective on the “system” of sprouting angiogenesis.
MODELING SPROUTING ANGIOGENESIS
Although many theoretical models of angiogenesis are rooted in mathematics and employ
numerical techniques to describe physical phenomena according to fundamental laws (e.g.
thermodynamics, conservation of mass, etc.), they are almost always grounded in empirical
data. Indeed, the recent explosion in available data due to the emergence of high-throughput
analyses, precise molecular assays, and a wide range of experimental models has greatly
facilitated the ability to determine both the conceptual models and detailed parameters
needed for constructing theoretical models of angiogenesis. This, coupled with faster
computer processing speeds, parallel computing, and user-friendly programming interfaces,
has greatly facilitated the generation of computational models of angiogenesis in recent
years.
There are as many ways to theoretically model biological processes as there are
experimental tools. It is now possible to integrate computational models and experimental
data to better understand blood vessel sprouting - and one approach that is currently in wide
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use is very simplistically stated as follows: 1) build the computational model based on
experimentally-derived knowledge (e.g. obtain model parameters directly from empirical
data), 2) validate the model by comparing its predictions to independent experimental
parameters (i.e. not ones that were used to construct the model), 3) challenge the model to
predict the outcome of a new and different set of simulated conditions (i.e. test a novel
hypothesis and/or generate new hypotheses). There are many excellent, recent studies in the
literature that have used this approach for developing and employing computational models
to investigate mechanisms of capillary sprouting angiogenesis (Figure 3). Recent models can
be loosely binned into those that have studied the environmental milieu with molecular
detail (e.g. growth factor concentrations and concentrations of ligand/receptors) and those
that have focused on cell behaviors and cell-cell communication.
Theoretical ligand-receptor kinetic binding models have yielded important quantitative
insights about VEGF signaling within tumors [25*] and muscle [26*], primarily because of
their ability to predict what cannot be measured experimentally in vivo: concentration
gradients of VEGF and its receptors. Most recently, a 3-dimensional reaction-diffusion
model of VEGF ligand-receptor kinetics and transport was developed to explore how VEGF
isoform gradients form around angiogenic sprouts [27*]. The model simulated what would
happen to VEGF isoform gradients in tissue when the relative roles of heparan sulfate
proteoglycans (HSPGs) vs. protease cleavage were varied. The study proposed an important
reinterpretation of the relative roles of HSPGs vs. VEGF-cleaving proteases in the control of
VEGF patterning in vivo: that the spatial localization of VEGF in tissues is governed by
isoform-specific degradation or clearance instead of HSPG binding-mediated diffusion.
Our group recently developed a computational model of dynamic spatial transport of VEGF
and its binding to receptors VEGFR-1 and VEGFR-2 in the context of a single blood vessel
to investigate mechanisms of sprout emergence and guidance [28*]. Specifically, we
explored the hypothesis that endothelial secretion of sFlt-1 sequesters local VEGF and
influences sprout emergence from parent vessels [6]. We ran simulations where the lengths
and distances between sprouts were intentionally and systematically varied, a feat that is
difficult to accomplish in vivo. The model also computed important concentration gradients
at resolutions that are not easily measured in vivo, such as active Flk-1 levels, free VEGF,
and free sFlt-1. The model predicted that increased local sFlt-1 sequestration of VEGF
results in decreased VEGF-Flk-1 levels but increases the relative gradient of VEGF-Flk-1
along the sprout surface, which could impact sprout spacing and emergence angle. Thus,
while individual cell behaviors were not explicitly represented in this model, it predicted
that sprouts influence how nearby sprouts perceive VEGF and affect “guidance” in a sFlt-1-
mediated manner.
A popular modeling approach that has been used to study cell behaviors and cell-cell
communication in sprouting angiogenesis is agent-based modeling (ABM) [29, 30]. Unlike
the molecular kinetics models mentioned above, ABMs simulate discrete cells that behave
autonomously according to a set of “rules” that are derived from experimental findings.
Frequently these rules embody the stochastic, or random, behaviors of cells. The model
output represents the emergent behavior of the system that results from the aggregate of
interactions amongst individual cells. Bentley et al. developed an agent-based model of
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VEGF tip cell induction that included inhibition by Notch/Dll4 [31]. Importantly, the model
predicted, for the first time, that lateral inhibition by Notch/Dll4 is depends on the level of
VEGFR-2 signaling. Moreover, in high VEGF concentrations the model predicted a
synchronous oscillation in tip/stalk phenotype across patches of cells; these oscillations are
supported by fixed images of retinal vessels but remain to be proven.
While many ABMs have been developed to aid in basic research [32, 33*, 34*], a recent
ABM was designed to meet the more applied goal of designing vascularized tissue
engineered constructs. Cinar et al. developed an ABM that included sprout initiation,
guidance, extension, and anastamosis to investigate the relationship between pore size of an
ex vivo scaffold and the rate of invasive angiogenesis [35**]. Scaffolds with larger pore size
(160–270 mm) were predicted to accelerate angiogenesis, a finding that was validated
against independent in vitro experiments using porous poly(ethylene glycol) hydrogels.
Like ABMs, Cellular Potts (Glazier-Graner-Hogeweg) modeling simulates collections of
discrete cells and has been applied to the study of angiogenesis. Most recently, this approach
was employed to examine the role of contact-inhibited chemotaxis in sprout extension [36].
The model predicted that VE-cadherin–mediated contact inhibition of chemotaxis in the
presence of a rapidly decaying secreted chemoattractant was sufficient to recapitulate
aspects of capillary sprouting. It also underscored the importance of contact-dependent
inhibition of pseudopod extension in generating proper branching and implicated VE-
cadherin in this process, which aligns nicely with experimental work in the murine allantois
explant assay showing decreased endothelial cell motility with VE-cadherin inhibition [37].
CONCLUSION
The increased sophistication of experimental tools and datasets has increased our knowledge
of the players involved in angiogenic sprouting, and it has set the stage for utilizing these
data, along with theoretical computational models, to better understand the interplay and
integration of both signals and cell behaviors that characterize angiogenesis. In parallel, the
increased robustness of computational models has already provided novel insights into
regulation of blood vessel formation. The next era of analysis will focus on several
challenges. First and foremost, we should use both experimental and computational tools to
better understand the important signaling nodes at the molecular level, as well as the
relevant cell behaviors that lead to productive sprouting; in this regard considering
angiogenesis as a multi-staged process should be helpful. This will also require the
development of new multi-scale computational models that span genetic, molecular, and
cell-to-tissue level interactions [38, 39*]. It is also important to understand how quantitative
differences in parameters and graded responses affect spouting, since most current
conceptual models are based on binary on/off inputs and outputs. Finally, it is a challenge to
understand the temporal aspects of blood vessel sprouting – it is a dynamic process, but the
time scale and parameters are poorly understood. In this challenge both the high resolution
live imaging now possible, and the ability to run simulations computationally, should be
powerful tools to better elucidate the time dimension.
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• Experimental tools are being developed that harness high-resolution microscopy
and precise molecular manipulations in order to produce detailed descriptions of
in vitro and in vivo sprouting angiogenesis.
• The development of new theoretical approaches, in parallel, provides
quantitative and systems-level information about sprouting angiogenesis that is
difficult to obtain and integrate without the help of computers.
• The next frontier is integration of experimental and computational approaches to
provide a sophisticated understanding of the complex process of sprouting
angiogenesis
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Fig. 1. A systems-level perspective to studying angiogenesis
Legend: The typical reductionist approach enables close examination of a few interacting
signals (dark gray) within a sub-module of the system, and linkages between signaling
modules (dashed lines) within entire networks are often inferred or hypothesized. In
contrast, computational models can provide systems-level perspectives through the prism of
biological complexity, contextualizing the comprehensive network of signaling modules that
give rise to system behaviors and how they change over time to produce different states
(light gray).
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Fig. 2. Stages of angiogenesis
Legend: Time lapse images of ES cell-derived vessels demonstrating the four “stages” of
endothelial sprouting angiogenesis described in the text: a) sprout initiation, b) sprout
guidance (e.g. through a channel created by sFlt-1 binding VEGF around adjacent stalk
cells), c) sprout extension, and d) sprout anastomosis. Endothelial cells (white) of mouse ES
cell-derived vessels have been genetically modified to express eGFP and visualized using
confocal microscopy. Time stamps = time elapsed (hr) since start of run. (Images courtesy
of Dr. John Chappell, Ph.D., University of North Carolina)
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Fig. 3. Summary of computational models of angiogenesis that span different stages
Legend: Each of the multi-scale computational models described in the text is of a particular
type – primarily agent-based (cell-centric) or reaction-diffusion (molecule-centric). The
models can be classified according to the stages of sprouting angiogenesis that they
simulate, as well as the biological components (molecules, cells, vessels, parenchymal cells)
that they include. Each model also has a different simulation size, ranging from a single
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sprouting vessel to a complex multi-vessel network. In each case the citation number refers
to the reference list in the main text.
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